The foods were sent to one of Europe's top laboratories,
GeneScan in Germany to look for GM maize which
cannot legally be sold in Europe. They analysed the
foods using Polymerase Chain Reaction (PCR) scanning
firstly for Monsanto's GM maize 'GA21' and then for
other unapproved varieties. They did this by looking for
the novel '35s/BAR' gene and when results for this gene
were positive, further PCR scanning was used to identify
the exact GM variety.
| Product | Purchase details | Monsanto GA21 |
| Asda own- brand | UK 12/10/00 | . |
| Safeway own- brand | UK 12/10/00 | . |
|
Phileas Fogg Authentic |
UK 17/10/00 | . |
According to the EU's Scientific Committee on Plants
(SCP), the novel protein has been tested on mice and the
whole grain has been used in a chicken feeding study.
Legal situation
Monsanto's GA21 maize is not approved in Europe.
Before GM crops can be sold in the EU they must obtain
both a marketing approval and a 'novel food' safety
approval. GA21 has neither.
Applications for EU marketing approval of this maize
were made by Monsanto in 1997 and 1998. In September
2000 the EU's Scientific Committee on Plants produced
an opinion on GA21, in which they stated that there is
no evidence to indicate that the placing on the market of
the modified maize (Zea mays) line GA21 with tolerance
to glyphosate herbicide is likely to cause any adverse
effects on human heath and the environment. However,
member states have yet to decide whether they agree
with this opinion, and approve GA21 for sale.
In 1998, Monsanto made an application for Novel Foods
safety approval (through the Netherlands). It is this
which determines whether a GM crop is considered safe
for consumption in Europe. When the UK's advisory
committee on GM foods (The Advisory Committee on
Novel Foods and Processes - ACNFP) looked at
Monsanto's application in March 2000, they concluded
that there was insufficient information on whether or not
the novel protein in GA21 could cause allergies.3 The
EU's top committee on GM foods, the Scientific
Committee on Foods (SCP) was asked to look at GA21
in June 2000 but they have not yet produced an opinion.
According to a leaked report from Monsanto, seven
European countries have objected to the Novel Food
application for GA21 - Austria, Belgium, Denmark,
Greece, Ireland, Italy and Sweden.4
The GM maize resists insect pests by producing a novel
protein called CRY1Ac Delta-Endotoxin and production
of the novel PAT protein allows it to break down the
herbicide. These proteins are produced in the grains.
No application for food safety approval of DBT 418 has
been made in Europe. Dekalb did apply for permission
to market this maize in 1997. But when the UK's
advisory committee on GM foods (the ACNFP)
considered the application in 1998, they stated that they
could not agree to the marketing of it for animal feed.
This is due to the presence of four resistance genes for
the antibiotic ampicillin, and the fact that the genes
contained structures which could allow them to be used
by bacteria in the intestines of livestock unless they were
completely broken down by processing.5
At the end of 1998, the EU's scientific committee on
plants was asked to look at the safety of Dekalb's GM
maize, but in March 1999, before they had published an
opinion, Dekalb's application for marketing approval
was withdrawn.
FOE recommends that:
* food retailers remove all illegal foods from sale.
* immediate action by food manufacturers to
ensure that their products are GM-free
* all shipments of maize, soya and oilseed rape
coming into Europe from countries known to
grow GM crops to be tested and fully-certified
as GM-free at port
* a full criminal investigation is carried out by the
appropriate authorities
* sufficient resources given to the appropriate
enforcement authorities such as Trading
Standards
* a specific GM liability regime is introduced at
an EU level that channels liability to the biotech
companies.
Tel 020 7490 1555
Fax 020 7490 0881
Email: info@foe.co.uk
References
1. Monsanto Application for consent to market grain
and derived products from Roundup Ready maize line
GA21 and its progeny. C/GB/97/M3/2
2. SCP Opinion of the SCP on the submission for
placing on the market of genetically modified maize (zea
mays) line GA21 with tolerance to glyphosate herbicide
notified by Monsanto September 2000.
3. Food Standards Agency.
www.foodstandards.gov.uk/maff/archive/food/novel/p
q585att.htm
4. Monsanto Regulatory Affairs + Scientific Outreach
Monthly Summary May and June 2000. Leaked to
Genewatch UK.
5. ACRE Index of Public Register Entries for
notification to market GMOs under Directive
90/220/EEC